74 related articles for article (PubMed ID: 10216510)
1. Mitoxantrone in elderly patients with advanced breast cancer: pharmacokinetics, marrow and peripheral hematopoietic progenitor cells.
Repetto L; Vannozzi MO; Balleari E; Venturino A; Granetto C; Bason C; Simoni C; Prencipe E; Queirolo P; Esposito M; Ghio R; Rosso R
Anticancer Res; 1999; 19(1B):879-84. PubMed ID: 10216510
[TBL] [Abstract][Full Text] [Related]
2. Mitoxantrone in elderly women with advanced breast cancer: a phase II study.
Repetto L; Simoni C; Venturino A; Biancardi V; Gasco M; Campora E; Rosso R
Anticancer Res; 1995; 15(5B):2297-300. PubMed ID: 8572641
[TBL] [Abstract][Full Text] [Related]
3. A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer.
Hu WW; Long GD; Stockerl-Goldstein KE; Johnston LJ; Chao NJ; Negrin RS; Blume KG
Clin Cancer Res; 1999 Nov; 5(11):3411-8. PubMed ID: 10589752
[TBL] [Abstract][Full Text] [Related]
4. Plasma and cellular pharmacokinetics of mitoxantrone in high-dose chemotherapeutic regimen for refractory lymphomas.
Canal P; Attal M; Chatelut E; Guichard S; Huguet F; Muller C; Schlaifer D; Laurent G; Houin G; Bugat R
Cancer Res; 1993 Oct; 53(20):4850-4. PubMed ID: 8402672
[TBL] [Abstract][Full Text] [Related]
5. First-line intra-arterial chemotherapy (IAC) with epirubicin and mitoxantrone in locally advanced breast cancer.
Fiorentini G; Tsetis D; Bernardeschi P; Varveris C; Rossi S; Kalogeraki A; Athanasakis E; Dentico P; Kanellos P; Biancalani M; Almarashdah S; Zacharioudakis G; Saridaki Z; Chalkiadakis G; Xynos E; Zoras O
Anticancer Res; 2003; 23(5b):4339-45. PubMed ID: 14666649
[TBL] [Abstract][Full Text] [Related]
6. A novel anti-inflammatory function of human galectin-1: inhibition of hematopoietic progenitor cell mobilization.
Kiss J; Kunstár A; Fajka-Boja R; Dudics V; Tóvári J; Légrádi A; Monostori E; Uher F
Exp Hematol; 2007 Feb; 35(2):305-13. PubMed ID: 17258079
[TBL] [Abstract][Full Text] [Related]
7. Low-dose radiation (LDR) induces hematopoietic hormesis: LDR-induced mobilization of hematopoietic progenitor cells into peripheral blood circulation.
Li W; Wang G; Cui J; Xue L; Cai L
Exp Hematol; 2004 Nov; 32(11):1088-96. PubMed ID: 15539087
[TBL] [Abstract][Full Text] [Related]
8. Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.
Kröger N; Damon L; Zander AR; Wandt H; Derigs G; Ferrante P; Demirer T; Rosti G; ; ;
Bone Marrow Transplant; 2003 Dec; 32(12):1153-7. PubMed ID: 14647269
[TBL] [Abstract][Full Text] [Related]
9. G-CSF during large field radiotherapy reduces bone marrow recovery capacity.
Pape H; Orth K; Heese A; Heyll A; Kobbe G; Schmitt G; Niederbichler AD; Peiper M; Schwarz A; Boelke E
Eur J Med Res; 2006 Aug; 11(8):322-8. PubMed ID: 17052967
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of the MDR inhibitor Incel (biricodar, VX-710) in combination with mitoxantrone and prednisone in hormone-refractory prostate cancer.
Rago RP; Einstein A; Lush R; Beer TM; Ko YJ; Henner WD; Bubley G; Merica EA; Garg V; Ette E; Harding MW; Dalton WS
Cancer Chemother Pharmacol; 2003 Apr; 51(4):297-305. PubMed ID: 12721757
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancer.
Schrama JG; Baars JW; Holtkamp MJ; Schornagel JH; Beijnen JH; Rodenhuis S
Bone Marrow Transplant; 2001 Jul; 28(2):173-80. PubMed ID: 11509935
[TBL] [Abstract][Full Text] [Related]
12. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
Benedetti G; Patoia L; Giglietti A; Alessio M; Pelicci P; Grignani F
Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
[TBL] [Abstract][Full Text] [Related]
13. Efficacious but insidious: a retrospective analysis of fludarabine-induced myelotoxicity using long-term culture-initiating cells in 100 follicular lymphoma patients.
Janikova A; Koristek Z; Vinklarkova J; Pavlik T; Sticha M; Navratil M; Kral Z; Vasova I; Mayer J
Exp Hematol; 2009 Nov; 37(11):1266-73. PubMed ID: 19654036
[TBL] [Abstract][Full Text] [Related]
14. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
Rosenblum MG; Verschraegen CF; Murray JL; Kudelka AP; Gano J; Cheung L; Kavanagh JJ
Clin Cancer Res; 1999 May; 5(5):953-61. PubMed ID: 10353726
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow connexin-43 expression is critical for hematopoietic regeneration after chemotherapy.
Presley CA; Lee AW; Kastl B; Igbinosa I; Yamada Y; Fishman GI; Gutstein DE; Cancelas JA
Cell Commun Adhes; 2005; 12(5-6):307-17. PubMed ID: 16531325
[TBL] [Abstract][Full Text] [Related]
16. Impaired bone marrow hematopoietic progenitor cell function in rheumatoid arthritis patients candidated to autologous hematopoietic stem cell transplantation.
Porta C; Caporali R; Epis O; Ramaioli I; Invernizzi R; Rovati B; Comolli G; Danova M; Montecucco C
Bone Marrow Transplant; 2004 Apr; 33(7):721-8. PubMed ID: 14743200
[TBL] [Abstract][Full Text] [Related]
17. High-dose sequential epirubicin and cyclophosphamide with peripheral blood stem cell support for advanced breast cancer: results of a phase II study.
Cottu PH; Extra JM; Espie M; Marolleau JP; de Roquancourt A; Makke J; Miclea JM; Laurence V; Mayeur D; Lerebours F; Cuvier C; Marty M
Br J Cancer; 2001 Nov; 85(9):1240-6. PubMed ID: 11720455
[TBL] [Abstract][Full Text] [Related]
18. Elderly ovarian cancer: treatment with mitoxantrone-carboplatin.
Nicoletto MO; Artioli G; Donach M; Sileni VC; Monfardini S; Talamini R; Veronesi A; Ferrazzi E; Tumolo S; Visonà E; Amichetti M; Endrizzi L; Salvagno L; Prosperi A; Azzoni P
Gynecol Oncol; 2001 Feb; 80(2):221-6. PubMed ID: 11161863
[TBL] [Abstract][Full Text] [Related]
19. A phase I and pharmacologic evaluation of the DNA intercalator CI-958 in patients with advanced solid tumors.
Dees EC; Whitfield LR; Grove WR; Rummel S; Grochow LB; Donehower RC
Clin Cancer Res; 2000 Oct; 6(10):3885-94. PubMed ID: 11051234
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients.
Cowan KH; Moscow JA; Huang H; Zujewski JA; O'Shaughnessy J; Sorrentino B; Hines K; Carter C; Schneider E; Cusack G; Noone M; Dunbar C; Steinberg S; Wilson W; Goldspiel B; Read EJ; Leitman SF; McDonagh K; Chow C; Abati A; Chiang Y; Chang YN; Gottesman MM; Pastan I; Nienhuis A
Clin Cancer Res; 1999 Jul; 5(7):1619-28. PubMed ID: 10430060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
